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Abstract
Background: Cysteine string protein (CSPa) is a synaptic vesicle protein that displays unique anti-neurodegenerative
properties. CSPa is a member of the conserved J protein family, also called the Hsp40 (heat shock protein of 40 kDa) protein
family, whose importance in protein folding has been recognized for many years. Deletion of the CSPa in mice results in
knockout mice that are normal for the first 2–3 weeks of life followed by an unexplained presynaptic neurodegeneration
and premature death. How CSPa prevents neurodegeneration is currently not known. As a neuroprotective synaptic vesicle
protein, CSPa represents a promising therapeutic target for the prevention of neurodegenerative disorders.
Methodology/Principal Findings: Here, we demonstrate that the flavonoid quercetin promotes formation of stable CSPa-
CSPa dimers and that quercetin-induced dimerization is dependent on the unique cysteine string region. Furthermore, in
primary cultures of Lymnaea neurons, quercetin induction of CSPa dimers correlates with an inhibition of synapse formation
and synaptic transmission suggesting that quercetin interfers with CSPa function. Quercetin’s action on CSPa is
concentration dependent and does not promote dimerization of other synaptic proteins or other J protein family members
and reduces the assembly of CSPa:Hsc70 units (70kDa heat shock cognate protein).
Conclusions/Significance: Quercetin is a plant derived flavonoid and popular nutritional supplement proposed to prevent
memory loss and altitude sickness among other ailments, although its precise mechanism(s) of action has been unclear. In
view of the therapeutic promise of upregulation of CSPa and the undesired consequences of CSPa dysfunction, our data
establish an essential proof of principle that pharmaceutical agents can selectively target the neuroprotective J protein
CSPa.
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Introduction
In neurons, there are significant demands on cellular folding
events. Complex interactions between multiple cellular compo-
nents underlie synaptic transmission, a process that occurs with
speed, precision and plasticity for extended periods of time.
Rigorous synaptic quality control mechanisms likely provide
defense against the detrimental effects of functionally impaired
synaptic proteins. Indeed, Huntington’s, Alzheimer’s, Parkinson’s,
Amyotrophic lateral sclerosis and prion diseases are caused by
defects in protein folding, underlying the biological importance of
the problem of aberrant protein folding in neurons. What synaptic
mechanisms mediate the balance between protecting proteins and
preventing accumulation of misfolded proteins remains a current
biological question.
Cysteine string protein (CSPa) is a 34 kDa synaptic vesicle
protein and molecular chaperone that is critical in the defense
against neurodegeneration. CSPa, so called because it contains a
25 amino acid domain comprising a string of 13–15 cysteine
residues, is a member of the conserved J protein family based on
the presence of a 70 amino acid signature J domain [1]. CSPa is
abundant in neural tissue and displays a characteristic localization
to synaptic vesicles [2] as well as clathrin coated vesicles [3].
Furthermore, CSPa null-organisms display widespread neurode-
generation [4–7]. Deletion of the CSPa gene generates mice that
are normal for the first 2–3 weeks of life followed by a progressive
loss of muscle strength and motor coordination, neurodegenera-
tion, blindness and premature death [5,6]. Although the
underlying molecular mechanisms of neurodegeneration in
CSPa-null mice have not yet been established, electron micro-
scopic analysis indicates that degeneration begins presynaptically
[5]. In Drosophila, CSPa knockout flies that survive to adulthood
show paralytic uncoordinated sluggish movements, spasmic
jumping, shaking and temperature sensitive paralysis. While the
precise sequence of pathogenic events remains to be identified, the
reported defects include a 50% reduction of nerve-evoked
neurotransmitter release at 18–22uC, a drastic reduction in evoked
release above 29uC, a reduced ability to maintain normal
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2+ levels and reduction of synaptic boutons at
neuromuscular junctions [8–13]. Reduction in synaptic transmis-
sion, temperature sensitive paralysis and premature lethality are
reversed by the expression of normal CSPa [9,10,12].
The J domain of CSPa interacts with and activates the ATPase
activity of Hsc70 (70 kDa heat shock cognate protein) [14,15] and
Hsp70 (70 kDa heat shock protein) [16]. Together with Hsc70 and
SGT (small glutamine-rich tetratricopeptide repeat domain
protein), CSPa assembles into an enzymatically active chaperone
complex [17,18]. Following activation of the heat shock response,
another member of the J protein family, Hsp40 (heat shock protein
of 40kDa) assembles with the CSPa complex [19]. The presence of
this chaperone complex on secretory vesicles suggests that CSPa is
a coordinating anchor in key conformation/activity change(s) of
client protein(s) critical in synaptic transmission. A number of
client proteins for the CSPa system have been proposed including:
G proteins, SNAREs (soluble N-ethylmalemide-sensitive factor
attachment receptor), synaptotagmin, rab3, voltage sensitive
calcium channels and CFTR (cystic fibrosis transmembrane
conductance regulator) [20] and it is likely that neurodegeneration
in null-organisms is due to the progressive misfolding and
accumulation of dysfunctional client protein(s).
It has been suggested that interference with CSPa function (eg
toxic proteins, environmental toxins) may be an underlying
mechanism leading to neurodegenerative diseases [5]. It follows
that relatively small changes to CSPa’s activity would be expected
to significantly affect neural survival, however there is currently no
direct support for this notion. In this study, we begin to address the
hypothesis that inhibition of CSPa activity may be common to the
pathological sequence of events that underlies neurodegenerative
disease and that the neuroprotective synaptic vesicle protein CSPa
represents a promising therapeutic target for the treatment or
prevention of neurodegeneration. Here we identify CSPa as a
target for quercetin, a naturally occurring flavonoid. The Western
diet contains ,25 mg/day of mixed flavonoids (quercetin ,70%).
Quercetin is particularly high in apple skins, green tea and red
grapes. It is also a major component of the nutrient supplements
Ginkgo Biloba and St. John’s Wort. Ginkgo Biloba is widely heralded as
a memory enhancer but is also commonly taken for altitude
sickness and cancer. St. John’s Wort is commonly taken for
depression. Ginkgo biloba leaves have been used for many centuries
in traditional Chinese medicine and justification for quercetin
supplements is historical rather than mechanistic. In this study we
show that quercetin promotes CSPa dimerization and inhibits
synaptic transmission as well as synapse development. The
identification of quercetin as an agent that targets CSPa is a first
step in the identification of pharmaceuticals that target members
of the large J protein family and as such serves as proof of principle
that pharmaceutical tools can selectively target J proteins. Given
CSPa’s anti-neurodegenerative properties, upregulation of CSPa
may hold therapeutic promise in protecting nerve terminals from
misfolded or toxic proteins [21].
Results
Quercetin stimulates formation of CSPa-CSPa dimers
70 kDa detergent-resistant CSPa dimers have been extensively
reported in rat brain [16,22,23], various cell lines [24,25] and
purified preparations [26] however, the role this dimer plays in
CSPa-mediated conformational work is not known. In order to
investigate the possibility that the neuroprotective synaptic vesicle
protein CSPa can be targeted by pharmaceutical agents, we
screened for drugs which initiate changes in CSPa dimerization.
Figure 1A shows that under control conditions, a small fraction of
total CSPa is detectable as a dimer in CAD cells (CNS-derived
catecholaminergic neuronal cells) in addition to monomeric CSPa
(both unmodified and palmitoylated). Post translational modifica-
tion of CSPa, involving extensive fatty acylation (*) results in its
retarded migration upon SDS-PAGE [22,27]. Interestingly,
Figure 1. Quercetin promotes CSPa dimerization. (A) CAD cells
were transiently transfected with 0.5 mg of c-myc-CSPa DNA and
treated with the indicated agent (200 mM quercetin, 1 mM geldanamy-
cin, 1.5 mM MPP
+, 0.2 mM H2O2 or 10 mM lactacystin) for 24 hours prior
to lysis. 40 mg of cellular protein was resolved by SDS-PAGE and CSPa
and Hsc70 were detected by Western analysis. b-actin is shown as a
loading control. (B) Chemical structure of quercetin dihydrate. (C) CAD
cells were transfected with 1.0 mg of c-myc-CSPa DNA and treated with
100 mM quercetin for 24 hours prior to lysis. 30 mg of protein was
heated at either 37uCo r8 0 uC for 10 minutes prior to being resolved on
an SDS-PAGE gel. CSPa was detected by Western analysis with a c-myc
antibody. Arrows indicate CSPa dimer at ,72 kDa; asterisks indicates
palmitoylated CSPa monomer at ,34 kDa. Data are representative of
three separate experiments.
doi:10.1371/journal.pone.0011045.g001
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CAD cells. The CSPa dimer was detected by Western analysis
with either anti-myc monoclonal or anti-CSPa polyclonal
antibodies. The structure of quercetin (3,39,49,5,7-pentapentahy-
droxyflavone), a common dietary flavonoid, is shown in
Figure 1B. In contrast to quercetin, the Hsp90 inhibitor
geldanamycin, the neurotoxin MPP
+, the oxidizing agent H2O2
and the proteasome inhibitor lactacystin, did not stimulate CSPa
dimerization, indicating that quercetin’s effect on CSPa is
selective. The quercetin-induced CSPa dimer is resistant to
disruption by incubation in SDS-containing sample buffer at
either 37uCo r8 0 uC( Figure 1C). SDS separates the vast majority
of cellular protein complexes to monomers by treatment 37uC and
more stable protein complexes at 80uC. The SDS and temperature
resistance of the CSPa-CSPa complex demonstrates the great
stability of the dimer. In contrast, no oligomerization or changes in
expression of Hsc70 were observed. Actin detection is shown as a
loading control. Our data demonstrate that the extremely stable
CSPa-CSPa complex is selectively increased by quercetin.
We then asked if quercetin has the same effect in rat cortical
neuronal cultures. Figure 2A shows that quercetin promoted
CSPa dimerization in a concentration (20 mM-100 mM) depen-
dent manner in cortical neurons expressing endogenous levels of
CSPa. Increases in dimer were detectable at 20 mM quercetin.
The expression levels of Hsc70 and Hsp40 chaperones which are
known to associate with CSPa [14,15,15,16,19], were not altered
by quercetin in treated cortical cultures. Actin is shown as a
loading control. No CSPa dimerization was initiated by the
DMSO vehicle control. The concentration-dependent induction
of the CSPa dimer by quercetin in CAD cells is shown in
Figure 2B. No changes in either the expression or formation of
dimers were observed for the chaperones Hsc70, Hsp40, Rdj2 or
the putative CSPa client proteins Gas and syntaxin, consistent
with findings in cortical neurons. Figure 2C shows that relative
differences in CSPa monomer and dimer expression are further
observed in different rat brain regions. The CSPa dimer was
highest in the thalamus, midbrain, entorhinal cortex and pons and
low in the spinal cord and medulla. Taken together, these results
show that a) in intact brain, the expression of CSPa-CSPa dimers
is region specific, b) in cortical neurons CSPa dimerization is
induced in the presence of quercetin in a concentration dependent
manner and c) quercetin does not cause a generalized oligomer-
ization of J proteins.
We next established the time course of quercetin’s induction of
CSPa dimers. Transfected CAD cells were treated with 100 mM
quercetin, lysed at 5 min, 8 hrs, 24 hrs, 48 hrs and the formation
of CSPa dimers evaluated by Western analysis with an anti-myc
antibody and quantified by Biorad multiimager and QuantityOne
software. Figure 3A shows that in the presence of quercetin the
CSPa-CSPa dimer is 4 fold higher at 24 hrs compared to control.
At 5 min, no difference in CSPa dimer expression was observed
between control and quercetin treated CAD cells transiently
expressing CSPa, suggesting that quercetin is acting to stabilize the
CSPa dimer. Consistent with these findings Figures 1 and 2
Figure 2. Quercetin exerts a concentration-dependent effect
on the formation of the CSPa dimer in rat cortical neurons and
CAD cells. (A) Western blot of cultured rat cortical neurons were
treated with indicated concentrations of quercetin for 24 hours prior to
lysis. Equal amounts of cellular protein were resolved by SDS-PAGE as
confirmed by ponceau S staining. (B) CAD cells were transiently
transfected with 1.0 mg c-myc-CSPa DNA and treated with indicated
concentrations of quercetin for 24 hours prior to lysis. Following
separation of cellular protein (30 mg) by SDS-PAGE, CSPa, Hsc70, Hsp40,
Rdj2, syntaxin and Gas were detected by Western analysis. b-actin is
shown as a loading control. Data are representative of three separate
experiments. (C) Native CSPa was detected in adult rat brain by
Western analysis with a monoclonal anti-CSPa antibody. Twenty-five
micrograms of unfractionated tissue homogenate isolated from the
indicated regions of rat brain were separated by SDS-PAGE, transferred
to PVDF and probed. Arrows indicate the CSPa dimer at ,72 kDa;
* indicates a palmitoylated CSPa monomer at ,34 kDa. Actin is shown
as a loading control.
doi:10.1371/journal.pone.0011045.g002
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heterologous protein, (i.e. transient expression in CAD cells) or
present under native conditions (i.e. cortical neurons), quercetin
increases dimer expression and this increase is likely due to
enhanced dimer stabilization. In addition, the proteosome
inhibitor lactacystin was not found to promote CSPa dimerization
indicating that quercetin is not working as a general proteosome
inhibitor. While these data are consistent with a direct interaction
between CSPa and quercetin, they do not permit us to rule out the
possibility that quercetin acts indirectly to initiate CSPa dimers.
To investigate this possibility, we tested the ability of quercetin to
directly inititate dimerization of purified recombinant soluble
CSPa. Figure 3B shows that quercetin triggered dimerization of
recombinant CSPa in a concentration dependent manner; we
further observed that quercetin promoted dimerization of CSPa in
a crude rat brain homogenate (data not shown), demonstrating
that quercetin action on CSPa is direct.
To identify which amino acids are important for quercetin-
induced CSPa-CSPa dimer formation, we transfected CAD cells
with a CSPa truncation construct CSPa1–82 that encodes only the
J domain, a CSPa deletion construct lacking the cysteine string
region amino acids 113–136, CSPaD, or the neural J protein Rdj2
(also called DnaJA2). The lack of quercetin-induced dimerization
of CSPa1–82, CSPaD or Rdj2 clearly identifies the cysteine string
region (residues 113–138) to be critically involved in dimerization
(Figure 3C). Rdj2 has a J domain and although it contains 11
cysteines throughout its amino acid sequence, it has no cysteine
string region. The cysteine string region is a unique region to
CSPa absent in other J proteins, emphasizing the notion that
drugs may selectively target unique regions, thereby targeting
distinct members of the J protein family. Taken together
Figures 1, 2 and 3 demonstrate that quercetin selectively and
directly interacts with CSPa to promote formation of highly stable
CSPa-CSPa dimers and that this process is dependent on the
cysteine string region of CSPa.
Quercetin inhibits synapse formation and synaptic
transmission
Deletion of CSPa is ultimately linked to a state where the
integrity of synaptic terminals is compromised. Therefore, the
ability of quercetin to target CSPa prompts the question: does
quercetin promote or inhibit synaptic function? To discern
between these possible senarios we evaluated synapse formation
in the fresh water snail Lymnaea stagnalis primary neuronal culture
model that is uniquely suitable for precise measurements of
synaptic transmission at a resolution not achievable elsewhere. In
these experiments, the functionally defined respiratory neurons
VD4 (visceral dorsal 4; presynaptic, cholinergic) and LPeD1 (left
pedal dorsal 1; postsynaptic) were plated with their somata
juxtaposed onto poly-L-lysine-coated dishes and the excitatory
synapses allowed to develop for 12–18 hrs either in the presence or
absence of 25 or 100 mM quercetin (Figure 4A). Prior to
intracellular recordings, quercetin was washed off for 1 to 2 hrs
and VD4 presynaptic action potentials and LPeD1 excitatory
postsynaptic potentials (EPSP) were recorded. As expected, in
control synapses, current injection-induced action potentials in
VD4 generated 1:1 EPSPs with averaged amplitudes of
9.861.7 mV in LPeD1 (n=8) (Figure 4A and B) similar to that
seen in vivo [28–30]. However, in the presence of 25 mM quercetin,
the mean amplitude of evoked EPSPs was significantly reduced to
2.560.7 mV (n=5, p,0.05) (Figure 4A and 4B, insert). Five
VD4/LPeD1 cultures failed to form synapses in the presence of
100 mM of quercetin, while synaptic transmission was detected in
3 neuron pairs but with greatly reduced amplitude (0.6+0.4 mV)
Figure 3. Quercetin increases the stability of the CSPa dimer in
CAD cells. (A) CAD cells were transfected with 1.0 mg of c-myc CSPa
DNA and treated with 100 mM quercetin as shown. Cells were lysed at
indicated times following quercetin treatment. 30 mg of protein was
resolved. Upper panel: CSPa was detected by Western analysis with the
c-myc antibody. Lower panel: Quantification of the CSPa dimer at 5
minutes and 24 hours in control and quercetin-treated cells. Results are
expressed as mean +/2 SE for a total of 4 separate experiments. (B)
Equal volumes of purified recombinant rat CSPa were treated with
indicated concentrations of quercetin for 24 hrs (C) CAD cells were
transfected with 1.0 mg CSPa1–198, CSPa1–82, CSPaDc and Rdj2 DNA and
treated with 100 mM quercetin for 24 hours. Arrows indicate CSPa
dimer at ,72 kDa. Data are representative of three separate
experiments.
doi:10.1371/journal.pone.0011045.g003
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potential firing in 90% of presynaptic VD4 cells examined (n=21)
(Figure 4A). We next measured the amplitude of potentiated
EPSP (pEPSP) following a tetanus compared to the amplitude of
the EPSPs before tetanus (Figure 4B, insert). The ratio of
pEPSP and EPSP was significantly reduced by 100 mM (n=8) but
not by 25 mM (n=5) of quercetin. Overall, our data establish that
quercetin impaired synapse formation and reduced synaptic
plasticity in Lymnaea and thus support the hypothesis that quercetin
targets and inhibits CSPa function leading to a loss of synaptic
integrity.
As expected, Western blot analysis revealed both CSPa
monomers and quercetin-induced CSPa-CSPa dimers in Lymnaea
(Figure 5A). Lymnaea were maintained in pond water containing
100 mM quercetin for 12–18 hrs and the VD4 ganglia were then
harvested and neuronal proteins were resolved by SDS-PAGE.
Native CSPa was detected by Western analysis with the CSPa
Figure 4. Quercetin inhibits synapse formation in Lymnaea
stagnalis primary cultured neurons. The presynaptic, cholinergic
neuron, visceral dorsal 4 (VD4) and the postsynaptic neuron, left pedal
dorsal 1 (LPeD1) were juxtaposed and cultured in the absence or
presence of quercetin (25 or 100 mM) for 12–18 hours. Prior to
intracellular recordings, quercetin was washed off. (A) Sample traces
of presynaptic action potentials on VD4 cells and excitatory postsyn-
aptic potentials (EPSPs) on LPeD1 cells. (B) The mean amplitude of EPSP
and the ratio of potentiated EPSP (pEPSP) over EPSP was reduced in the
presence of both 25 mM quercetin (n=5) and 100 mM quercetin (n=7)
(inserts). Statistical significance was determined using Students’ t-test.
* indicates significant difference at the level of p=0.05. Error bars
indicate S.E.
doi:10.1371/journal.pone.0011045.g004
Figure 5. Quercetin induces the CSPa dimer in Lymnaea
stagnalis. (A) Lymnaea were maintained in pond water containing
100 mM quercetin over night as indicated prior to harvesting of the VD4
ganglia from several snails. Equal numbers of ganglia were combined
and resolved on a gel. Native CSPa was detected by Western analysis
with the CSPa polyclonal antibody. The panels shown are from the
same experiment and are representative of three independent
experiments. Arrow indicates CSPa dimer at ,72 kDa. Hsc70 is shown
as a loading control. (B) Paired Lymnaea soma were cultured overnight
and subjected to immunostaining with CSPa polyclonal antibody.
Stacks of 0.28 mm slices were collected and collapsed into Z projections
in maximum intensity using ImageJ. Images are representative of five
experiments.
doi:10.1371/journal.pone.0011045.g005
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Quercetin-induced CSPa dimer formation in Lymnaea respiratory
neurons (Figure 5A) was similar to that found for transfected
CAD cells and cortical neurons (Figures 1 and 2). Confocal
microscopy confirmed that CSPa is abundant in paired Lymnaea
neurons, with highest localization observed at the plasma
membrane (Figure 5B). No signal was obtained with either
quercentin alone or secondary antibody alone (data not shown). In
addition to Lymnaea, CSPa homologues have been reported in
Torpedo, Xenopus, Drosophila and numerous mammals; this high
degree of evolutionary conservation of the CSPa system makes a
strong case for an important cellular function. Of course, J proteins
are even more extensively conserved and have been reported in
bacteria, plants and viruses [20] where they most certainly are
involved in conformational work. Our data provide unequivocal
evidence that the the sensitivity of the CSPa chaperone system to
quercetin is conserved from mammals to Lymnaea.
To ask whether the functional defects observed following
quercetin treatment of intact neurons were time dependent, we
next tested the effects of acute application of quercetin on synaptic
transmission. Strikingly, Figure 6 shows that bath application of
25 mM quercetin to functional VD4/LPeD1 cultured neurons
rapidly reduced synaptic transmission within 10 minutes. Neurons
were paired overnight and on day two, simultaneous pre- and
postsynaptic intracellular recordings under control conditions
clearly showed that induced action potentials in VD4 produced
1:1 EPSPs in LPeD1 and these were potentiated significantly after
a brief presynaptic tetanus. The amplitude of EPSPs in LPeD1 was
greatly diminished within minutes of perfusion with 25 mM
quercetin (Figure 6A) indicating that quercetin rapidly inhibited
synaptic transmission. A typical action potential is shown before
(red) and after (blue) exposure to quercetin. Quercetin prolonged
the presynaptic repolarization phase of the action potential,
thereby lengthening action potential duration and rendering the
neuron incapable of rapid and repetitive firing. Washout of
quercetin (10–20 min) did not reverse the reduction in EPSP
(Figure 6B) suggesting that quercetin-dependent alteration of
CSPa is irreversible in the short term. In the absence of an action
potential quercetin did not stimulate exocytosis and spontaneous
EPSPs were not observed following exposure to quercetin (data
not shown). Larger reductions in EPSP amplitude were observed
with 100 mM compared to 25 mM quercetin. The ratio of the pre-
tetanus EPSPs to that of post-tetanus was reduced following
quercetin treatment (Figure 6C) demonstrating a reduction in the
ability of neurons to exhibit short-term synaptic plasticity.
Even more telling, quercetin did not alter the post synaptic
response to acetylcholine (Figure 7A). Postsynaptic LPeD1 cells
were cultured overnight (12–18hrs) and 1 mM Acetylcholine
(ACh), the transmitter released from presynaptic VD4, was
exogenously applied before and after exposure to quercetin (25
or 100 mM) for 30 mins while the postsynaptic potential was
monitored. ACh elicited excitatory postsynaptic potentials which
triggered firing of action potentials both before and after the
exposure to either 25 or 100 mM quercetin for 30 mins (n=4). At
higher concentrations of quercetin LPeD1 action potentials
showed a slower rate of repolarization.
To further test for quercetin-induced changes in presynaptic
function, action potentials were recorded simultaneously with
intracellular Ca
2+ concentration [Ca
2+]i measurements before
and after perfusion of quercetin (25 mM) (Figure 7B). VD4 cells
were cultured overnight and then loaded with the fluorescent
Ca
2+ indicator, Fura-2 AM. Elevations in intracellular free
[Ca
2+] in response to single action potential and action potential
bursts were significantly reduced after exposure to quercetin for
20 mins (n=4) compared to control neurons (Figure 7B insert).
Because 100 mM quercetin induced action potential clamping
(Figure 4A and 6A), we opted to directly measure presynaptic
Ca
2+ currents (ICa) by whole cell voltage clamp with direct
depolarizing steps from holding potential of 280 mV to
+70 mV in 10 mV increments. Exposure to 100 mMq u e r c e t i n
Figure 6. Acute application of quercetin blocks synaptic
transmission in Lymnaea neurons. VD4 (presynaptic) and LPeD1
(postsynaptic) were co-cultured overnight, presynaptic action poten-
tials were induced and the amplitude of the excitatory post synaptic
potential (EPSPs) was measured. (A) Quercetin increased the presyn-
aptic repolarization phase of the action potential by predominately
rendering the neuron incapable of firing continuously (clamping of
tetanic bursts) *. The EPSP amplitude was greatly diminished within
minutes of perfusion with 100 mM quercetin. A typical action potential
and EPSP are shown before (red) and after (blue) exposure to quercetin.
(B) Summary of the effect of quercetin (25 and 100 mM) and following
wash out (10–20 mins) on the mean amplitude of action potential-
generated EPSPs. (C) Summary of the effect of quercetin (25 and
100 mM) and quercetin washout on the ratio of potentiated EPSP
(LPeD1) over EPSP. Statistical significance was determined using
Students’ paired t-test. * indicates significant difference at the level of
p=0.05. Error bars indicate S.E.
doi:10.1371/journal.pone.0011045.g006
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2+ current
(Figure 7c). Figure 7C left panel shows raw traces of ICa
induced by a depolarization step from 280 mV to +20 mV
before and after exposure to quercetin 100 mM for 15 min.
Normalized current-voltage relations of ICa, (Figure 7C right
panel) shows that the peak current occurred at +20 mV and the
normalized peak current was significantly reduced from a
control level of 0.9060.10 to 0.4960.10 (n=4, P,0.05) after
15 mins of 100 mM quercetin. These observations indeed
indicate that quercetin indeed rapidly inhibits action potential-
induced Ca
2+ entry and reduces synaptic transmission in
Lymnaea neurons, consistent with the hypothesis that quercetin
binds to and inactivates CSPa, leading to a sequence of events
that involves disabling ion channels (eg voltage sensitive Ca
2+
channels). We have previously shown that CSPa promotes G
protein-mediated inhibition of N-type Ca
2+ channels [23,31]
t h e r e b yd i r e c t l yr e g u l a t i n gC a
2+ channel activity. Of note, CSPa
has been suggested to be a Ca
2+ channel chaperone, but this
notion has been controversial [32–38]. In addition, previous
studies have concluded that quercetin is both an L type Ca
2+
channel activator [39] and inhibitor [40,41] as well as a BKCa
channel activator [42], Kir channel inhibitor [43] and Ca
2+
ATPase inhibitor [44,45]. Although our data in Lymnaea VD4/
LPeD1 respiratory neurons support the idea that quercetin’s
inhibition of CSPa activity leads to downstream inhibition of
synaptic transmission, these findings together with the above
stated reports could potentially also be explained by a direct
block of presynaptic Ca
2+ channels by quercetin. Previous
studies have demonstrated that lowering extracellular Ca
2+ also
blocks synapse formation between cultured Lymnaea neurons
[46] showing the importance of Ca
2+ in the activation of
synaptogenesis.
To establish more definitely if channel blockers generally altered
CSPa dimer levels, we again utilized the transiently transfected
CAD cell model. No significant differences in CSPa dimer
formation was observed following treatment of transiently
transfected CAD cells with CdCl2, nifedipine, D-2-amino-5-
phosphonovalerate (D-APV) or tetrodotoxin (TTX) (Figure 7C).
Furthermore, lowering cytosolic free [Ca
2+] by incubation with the
membrane permeable Ca
2+ chelator BAPTA-AM (20 mM), a Ca
2+
chelator, for 1 hour did not stimulate CSPa dimer formation or
influence quercetin’s induction of the dimer. Taken together, these
data indicate that none of the channel blockers examined
promoted CSPa-CSPa dimer formation, suggesting that ion
channel block per se or reduction in cytosolic free Ca
2+ does not
stimulate CSPa dimerization, while quercetin impaired presynap-
tic Ca
2+ influx and reduced neuronal ability to maintain normal
Ca
2+ levels. Independent of whether quercetin directly targets
CSPa and secondarily disables channels or directly targets
channels as well as CSPa, the results shown in Figures 4, 5
and 6 demonstrate that quercetin promoted dimerization of
CSPa, reduced the amplitude of EPSPs in LPeD1 Lymnaea neurons
and rapidly triggered a prolongation of presynaptic repolarization
associated with inhibition of synaptic transmission and reduced
synapse formation.
Increases in the CSPa:CSPa dimer correlate with a
decrease in active CSPa:Hsc70 units
CSPa-mediated conformational work relies on the assembly of a
CSPa with the ATPase Hsc70 [14–17]. To analyze the influence
of quercetin on the assembly of the CSPa active chaperone
complex, CSPa was immunoprecipitated from CAD cells treated
with quercetin and the co-association of Hsc70 was evaluated. The
CSPa dimer, monomeric palmitoylated CSPa, and monomeric
unpalmitoylated CSPa immunoprecipitated from CAD cell
lysates. Following treatment with quercetin, higher levels of CSPa
dimer immunoprecipitated as expected. Immunoprecipitation of
the monomeric palmitoylated CSPa (but not the unpalmitoylated)
species was relatively lower following quercetin. Figure 8 shows
Figure 8. Quercetin reduces CSPa:Hsc70 association. Co-
immunoprecipitation of CSPa and Hsc70 from control and quercetin-
treated CAD cells followed by Western analysis. Immunoprecipitation
was achieved by incubating 300 mg CAD cell lysate with anti-myc
monoclonal, immunoprecipitated proteins were separated by SDS-
PAGE and evaluated by Western analysis with anti-CSPa polyclonal and
anti-Hsc70 monoclonal. Arrow indicates CSPa dimer at ,72 kDa. Data
are representative of three separate experiments.
doi:10.1371/journal.pone.0011045.g008
Figure 7. Quercetin does not alter the postsynaptic left pedal dorsal 1 (LPeD1) response to acetylcholine, but reduces action
potential or depolarization-induced Ca
2+ entry into the presynaptic neuron. (A) LPeD1 cells were cultured. Acetylcholine (ACh, 1 mM) was
exogenously applied before and after exposure to quercetin (25 or 100 mM) for 30 mins and postsynaptic potential was monitored. (B) Intracellular
recording of action potentials from cultured VD4 neurons before and after perfusion of quercetin (25 mM) were simultaneously made with the
measurement of cytoplasmic Ca
2+ concentrations using a Ca
2+ imaging technique. Single action potentials induced corresponding Ca
2+ transients
(insert) and burst of action potentials triggered a robust compound Ca
2+ rise. However the mean values of [Ca
2+] rise in response to single and bursts
of action potential were significantly reduced after exposure to quercetin for 20 mins (n=4). (C) Quercetin inhibited voltage-gated Ca
2+ currents (ICa)
in presynaptic VD4 neurons elicited by step depolarization of cells from 280 mV to +70 mV in 10 mV increments before and after exposure to
quercetin 100 mM for 10 mins. The left panal shows representative raw traces of ICa evoked by a square depolarization pulse from 280 mV to
+20 mV for 500 ms. The right panel shows normalized current-voltage relations of ICa (n=4). (D) CAD cells were transiently transfected with 0.75 mg
CSPa, treated with 1 mM tetrotodoxin (TTX), 50 mM D-2-amino-5-phosphonovalerate (D-APV), 50 mm nifedipine, 100 mm CdCl2 or 100 mM quercetin
for 24 hours. Right panel: CAD cells were treated with 100 mM quercetin for 24 hour, 20 mM BAPTA-AM 1 hour as indicated and 30 mg of cell lysate
was resolved by SDS-PAGE. Data are representative of three separate experiments.
doi:10.1371/journal.pone.0011045.g007
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indicating that quercetin inhibits assembly of the active chaperone
complex. These results suggest that the quercetin-induced changes
in CSPa dimerization and synaptic transmission involve inhibition
of CSPa chaperone activity.
Finally, we asked whether other flavonoids also elicit an increase
in the abundance of CSPa-CSPa dimers. Exposure to epigallo-
catechin gallate (EGCG) increased CSPa dimerization in CAD
cells like that observed for quercetin (Figure 9). The CSPa dimer
was detected by Western analysis with anti-myc monoclonal
antibody. Figure 9B shows that the ratio of CSPa dimer to
monomeric palmitoylated CSPa was higher following quercetin
treatment then EGCG treatment. Actin is shown as a loading
control. We conclude that quercetin and EGCG are potent
activators of CSPa dimerization and predict that the common
polyphenol structure is a central structure involved in increasing
CSPa dimerization.
Discussion
Our work fulfills the proof of principle that pharmacological
compounds like quercetin can target select members of the J
protein family to modulate their cellular behavior. Specifically, our
data show that the flavonoid, quercetin, interferes with CSPa
function to maintain synaptic integrity. A current working model
of the CSPa complex is illustrated in Figure 10. In this model,
CSPa is anchored to the secretory vesicle and on its own is
inactive. At least two other CSPa complexes exist: the active
Hsc70/SGT/CSPa complex, and the CSPa dimer. CSPa displays
unique anti-neurodegenerative properties and impairments in
CSPa activity lead to impairment in synaptic transmission. In our
model, quercetin targets CSPa, increases the abundance of stable
CSPa-CSPa dimers and reduces assembly of CSPa with Hsc70,
thereby reducing the folding capacity of the CSPa complex. CSPa
dimerization may be a cause for the inhibition of neurotransmis-
sion, synaptic plasticity and synapse formation, essential features of
normal brain function but other possibilities exist. Mechanistic
insight into neurodegeneration following CSPa-inoperation re-
mains limited but ultimately a reduction in synaptic folding
capacity and a progressive buildup of unfolded presynaptic client
proteins most likely creates a situation where the integrity of
synaptic terminals is compromised.
Quercetin does not initiate widespread oligomerization of J
proteins (Figures 2 and 3). The human genome encodes for over
40 J proteins with specific cellular and subcellular distributions [1].
The importance of the J protein family in protein folding has been
recognized for many years (Reviewed: [47,48]). Members of the J
protein family have a modular architecture in which a signature J
domain is grafted to other sequences that impose specific cellular
functions. The J domain is a 70 amino acid signature region
comprised of four helices with a highly conserved tripeptide of
histidine, proline and aspartic acid (HPD motif) located between
helices II and III that is critical for chaperone activity. Hsc70 is
targeted to a particular substrate through binding to the ‘‘J
domain’’ of its partner and regulates the conformation and activity
of the target protein via mechanisms that appear to involve cycles
of substrate binding and release, which are governed by ATP
binding and hydrolysis. Since J proteins are thought to provide the
basis for selective chaperone action in the cell they are also
promising therapeutic targets for the manipulation of specific
protein folding processes [21].
Many questions remain about the biochemical pathway(s)
responsible for CSPa-mediated neuroprotection. It is obvious
that the CSPa chaperone unit is highly conserved machinery
built upon the universal J domain/Hsc70 association and
contributes to presynaptic protection. Furthermore, it is known
that other J proteins do not compensate for the absence of
CSPa, consistent with the idea that CSPa is designed to
facilitate specific synaptic folding events and that the unfolded
CSPa client is toxic. That said, significant efforts towards
establishing the identity of CSPa client proteins and the
underlying molecular details of CSPa’s essential synaptic quality
control are ongoing. Regulators of the degeneration seen in
CSPa knockout models have been identified. Chandra and
colleagues have shown that a- s y n u c l e i n ,as m a l ln e u r a lp r o t e i n
whose biological function is unclear, selectively modulates the
CSPa neurodegeneration pathway [7]. CSPa deficient mice are
rescued from presynaptic degeneration and lethality by the
overexpression of a-synucein. Moreover, ablation of endoge-
nous a-synuclein accelerates the degeneration of presynaptic
terminals observed in mice lacking CSPa.F u r t h e r m o r e ,a-
synuclein specifically rescues CSPa deletion, but transgenic a-
synuclein does not rescue the spinal cord degeneration in mice
that express mutant superoxide dismutase. Precisely how a-
synuclein abolishes neurodegeneration triggered by the absence
of CSPa is unclear. Results reported here show that the cellular
Figure 9. Epigallocatechin gallate (EGCG) stimulates formation
of CSPa-CSPa dimers. (A) CAD cells were transiently transfected with
1.0 mg c-myc-CSPa DNA and treated with indicated concentrations of
EGCG for 24 hours prior to lysis. Following separation of cellular protein
(30 mg) by SDS-PAGE, CSPa, was detected by Western analysis. b-actin is
shown as a loading control. Arrow indicates CSPa dimer at ,72 kDa. (B)
Quantification of the CSPa dimer to monomeric palmitoylated CSPa
ratio under control, 100 mM quercetin and 200 mm EGCG conditions.
Numbers in parentheses indicate the numbers of experiments; error
bars denote standard errors.
doi:10.1371/journal.pone.0011045.g009
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presynaptic Ca
2+ and ii) an increase in the presynaptic
repolarization phase rendering neurons incapable of firing
continuously, diminishing the amplitude of EPSPs and prevent-
ing additional synapse formation. One possibility is that
following reduction of CSPa folding activity, a downstream
progressive misfolding of protein(s) central to Ca
2+ homeostasis
leads to inhibition of synaptic transmission. Another possibility
is that quercetin has cellular targets in addition to CSPa perhaps
directly blocking voltage dependent Ca
2+ channels. Although
the precise mechanism by which quercetin alters Ca
2+
homeostasis remains to be established in detail, it is notable
that lowering of cytosolic free [Ca
2+] with either the Ca
2+
chelator BAPTA-AM or the Ca
2+ channel blocker CdCl2 does
not stimulate CSPa dimerization, demonstrating that CSPa
dimerization is not a general cellular response to Ca
2+ channel
blockade. Independent of which explanation is correct, our
results illustrate that quercetin targets CSPa and impairs
synaptic function.
If quercetin is so powerful in inhibiting synaptic transmission,
why do so many choose to supplement their diet with flavonoid
mixtures (eg Ginkgo biloba)? Flavonoids are a class of compounds
with polyphenolic structures and in all likelihood a spectrum of
physiological functions can be expected depending on the position
of hydroxyls and side chains. Our results indicate that the common
structural features of quercetin and EGCG are important for
triggering CSPa dimerization (Figures 1 and 9). Such
compromised CSPa activity could contribute to the rate of
progression of neurodegenerative (misfolding) diseases (eg. Alzhei-
mer’s disease, Huntington’s disease) however there is no direct
evidence for this notion. Neurotoxicity would depend on the
flavonoid mixture utilized, metabolites and final concentration in
the CSF (cerebrospinal fluid) after oral intake. Not all related
compounds would necessarily inhibit CSPa activity, and it remains
to be established if select flavonoids would enhance rather than
inhibit CSPa function. Direct evidence supporting a role for
flavonoids in memory enhancement is currently not available.
In view of the crucial importance of CSPa in synaptic integrity,
our data identify a key role for compounds that interfere with its
specialized presynaptic function. We speculate that neuropatho-
logical abnormalities could be due to or exacerbated by toxins with
inhibitory actions towards CSPa similar to that of quercetin.
Conversely, compounds related to quercetin may be found to
enhance rather than inhibit CSPa activity. Thus, the identification
of quercetin as tool that selectively modulates CSPa’s neuropro-
tective function is a promising lead towards the identification of
agents that enhance CSPa’s neuroprotective function and thereby
have a high potential in therapy development for neurodegener-
ative diseases. Our study further predicts that compounds that
selectively target J proteins may have considerable potential as
novel therapeutic agents.
Materials and Methods
Reagents and chemicals
Anti-CSPa rabbit polyclonal was prepared as described
previously [22]. Anti-Hsp40 rabbit polyclonal were from Stress-
gen. Anti-Hsc70 mouse monoclonal, anti-b-actin mouse mono-
clonal, anti-syntaxin mouse monoclonal, quercetin, forskolin,
MPP
+ and lactacystin was from Sigma. Anti-c-myc mouse
monoclonal was from Clontech. Anti-CSPa mouse monoclonal
was from BD Biosciences. Anti-Gas rabbit polyclonal and
geldanamycin were from Calbiochem. Anti-Rdj2 mouse mono-
clonal was from Abnova. H2O2 was from VWR. ACh was
obtained from Research Biochemicals (Natick, MA; product A-
112)
CAD mouse neuroblastoma cells [49,50] were seeded into 6 well
plates and grown in DMEM/F12 medium supplemented with
10% fetal bovine serum and 1% penicillin/streptomycin as
previously described. For differentiation cells were grown in
Opti-MEM for 3 days. Cells were lysed in 40 mM Tris (pH 7.4),
150 mM NaCl, 2 mM EDTA, 1 mM EGTA, 1 mM Na3VO4,
0.1% SDS, 1% T-X100, 0.5 mM PMSF and protease inhibitor
(Sigma) at 4uC for 1 hour. Lysates were centrifuged at 150006g
Figure 10. Model depicting the inhibition of CSPa chaperone activity by quercetin. The synaptic vesicle protein CSPa has unique anti-
neurodegenerative properties. Distinct CSPa complexes exist: inactive, active (in complex with Hsc70 and SGT), and a CSPa dimer. Quercetin
promotes the CSPa dimer, inhibits assembly of the active CSPa complex and synaptic transmission.
doi:10.1371/journal.pone.0011045.g010
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concentration was determined using a Bradford style assay kit
(BioRad). For transient transfection, CAD cells were washed in
PBS and transiently transfected with c-myc tagged rat CSPa1–198
DNA using Lipofectamine-2000 (Invitrogen) in Opti-MEM and
maintained in culture for 24 hours prior to treatments.
Rat cortical neurons
Rat primary cortical neurons (Cryopreserved) were purchased
from QBM Cell Science (Ottawa, Canada) and stored in liquid
nitrogen. Prior to culture, cells were thawed and gently transferred
into pre-warmed neurobasal medium (Invitrogen, No. 21103-049)
supplemented with 2% B27 (Invitrogen, 17504-044). Cells were
then plated onto poly-D- lysine and laminin coated cover slips and
maintained in neurobasal medium for 7 days at 37uCi n5 %C O 2
prior to treatment with quercetin for 24 hours. Cells were
harvested with lysis buffer and equal volumes of protein lysate
were resolved by SDS-PAGE.
Lymnaea ganglia
Equal numbers of whole ganglia were harvested and lysed at
4uC for 40 minutes and resolved by SDS-PAGE.
Fresh water snails, Lymnaea stagnalis, were maintained at room
temperature (22–23uC) in a well-aerated aquarium containing
filtered pond water. Neurons were isolated from 1–2 month old
snails with a shell length of 20–22 mm and the Lymnaea brain-
conditioned medium was prepared using 3–6 month old animals
with a shell length of 25–30 mm. The cell isolation and cell culture
procedures have been described in detail elsewhere [51]. Briefly,
the Lymnaea were dissected and central ring ganglia were removed.
Following treatment with Trypsin (2 mg/ml) for 23 mins, the
central ring ganglia were then treated with trypsin inhibitor
(2 mg/ml) for another 15 mins. Identified presynaptic neuron
visceral dorsal 4 (VD4, cholinergic) and postsynaptic neuron left
pedal dorsal 1 (LPeD1) (for synaptogenesis and synaptic
transmission experiments) were isolated by applying gentle suction
through a fire-polished and Sigma-coat (Sigma, St. Louis, MO)-
treated pipette. Isolated cells were then plated onto poly-L-lysine
coated glass dishes in the presence of either medium (L-15; Life
Technologies, Gaithersburg, MD; special order) or conditioned
medium which contains trophic factors. Soma-soma synapses were
prepared by juxtaposing VD4 and LPeD1 cell bodies against each
other. The synapses developed overnight as described previously
and were tested through direct intracellular recordings [28].
Immunoblotting
Proteins were electrotransferred from polyacrylamide gels to
0.45 mm nitrocellulose membrane in 20 mM Tris, 150 mM
glycine and 12% methanol. Membranes were blocked with 4%
milk solution (prepared in PBS with 0.1% Tween 20) and
incubated with primary antibody for 2 hours at room temperature
or overnight at 4uC. The membranes were washed in blocking
solution and incubated with horseradish peroxidase-coupled
secondary antibody. Antigen was detected using West Pico reagent
(Pierce Biotechnology Inc.). Immunoreactive bands were visual-
ized following exposure of the membranes to Kodak film. Bound
antisera were quantitated by Biorad Fluor-S MultiImager Max
and QuantityOne 4.2.1 software.
Immunoflourescence
Lymnaea neurons were plated on coverslips and maintained in
Lymnaea brain conditioned medium with or without quercetin
overnight (12–18 hrs). Neurons were washed in PBS and fixed in
2% paraformaldehyde for 1 hour at room temperature then
washed 3 times with PBS for 10 minutes each. After blocking in
10% goat serum solution containing 0.3% Triton-X100 for 30
minutes cells were incubated with primary antibody in the
blocking solution for 2 hours at room temperature or overnight
at 4uC, washed 3 times with PBS for 10 minutes each, and
incubated with goat anti-mouse conjugated to Alexafluor 546
secondary antibody in the blocking solution for 1 hour at room
temperature. Cells were then washed 3 times in PBS for 10
minutes each, mounted with DABCO (Sigma) and photographed
with a confocal microscope (LSM 510 Meta, Zeiss, Germany)
under a 63X oil immersion objective at 543 nm excitation
wavelength and images were collected using a band-pass filter
(560–615).
Electrophysiology
Neuronal activity was recorded using conventional intracellular
recording techniques as described previously [30]. Glass micro-
electrodes (1.5 mm internal diameter; World Precision Instru-
ments, Sarasota, FL) with tip resistances of 20–50 MV were filled
with a saturated solution of K2SO4. Neurons were impaled using
Narashige (Tokyo, Japan) micromanipulators (MM202 and MM
204) (Axiovert 135; Zeiss, Thronwood, NY) on an inverted
microscope. To test for synaptic connections, current was injected
into the presynaptic neuron VD4 via an intracellular microelec-
trode which induced action potentials in the VD4 cell, and
postsynaptic responses in LPeD1. The recorded electrical signals
were displayed on a digital oscilloscope (PM 3394; Philips,
Eindhoven, Netherlands) and relayed through a digitizer (Digidata
1322A, MDS Inc, Toronto, Canada) and recorded on a computer
using Axoscope 9.0 software (MDS Inc, Toronto, Canada).
Acetylcholine (ACh, 1 mM) was pressure applied (10–20 psi, 0.5–
1 s duration) directly to the somata through a glass pipette (2–
4 mm tip diameter) connected to a PV800 pneumatic picopump
(World Precision Instruments).
Whole-cell recordings of voltage-gated Ca
2+ currents (ICa) were
performed using a Multiclamp 700B amplifier (Axon Instruments)
connected to an analog-to-digital interface Digidata 1322 (Axon
Instruments). Signals were acquired and stored on a personal
computer equipped with pClamp 9.2 software (Axon Instruments).
Borosilicate pipettes (A-M Systems, Inc, Sequim, WA) were pulled
using a Sutter P-97 microelectrode puller (Sutter) and the pipette
resistance was 3–7 MV after being filled with pipette solution
containing: 35 mM CsCl; 1 mM CaCl2; 2 mM MgATP; 10 mM
EGTA; 10 mM HEPES; adjusted to pH 7.4 with CsOH. The
external bath solutions used to isolate Ca
2+ currents contains:
10 mM CaCl2; 1 mM MgCl2; 45.7 mM TEA-Cl; 10 mM
HEPES; 5 mM 4-AP; adjusted to pH 7.9 with TEA-OH. ICa in
the presynaptic VD4 cells were elicited by depolarizing the cells
from a holding potential of 280 mV to +70 mV in 10 mV steps.,
The Ca
2+ current data were analyzed using Clampfit 9.0 software
(Axon Instruments) and traces were plotted using OriginPro 8.0
SRO (Northampton, MA, USA).
Ca
2+ imaging
Fura-2 AM (Molecular Probes, Carlsbad, CA), a membrane
permeable and ratiometric Ca
2+ sensor, was used to determine
changes in the intracellular Ca
2+ levels. A detailed Ca
2+
measurement procedure has been described elsewhere [52]. In
brief, neurons were loaded with Fura-2 AM (10 mM) at room
temperature (21–22uC) for 45 min. and were then exposed
alternately to excitation wavelengths 340 and 380 nm using a
high-speed wavelength switcher LAMBDA DG4 (Sutter Instru-
ment, Novato, CA). The emitted fluorescence signal was collected
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Northern Eclipse software running ionwave program (Empix
Imaging, Canada). The free intracellular Ca
2+ concentration
([Ca
2+]i) was estimated based on values obtained with a fura-2
Ca
2+ imaging calibration kit (F-6774, Molecular Probes) according
to [53].
Immunoprecipitation
Immunoprecipitation was achieved by incubating detergent
solubilized cells with the myc-monoclonal overnight at 4uC,
followed by protein A/G agarose for 2 hrs at 4uC. Samples were
washed, resuspended in 30ul of sample buffer, separated by SDS-
PAGE, transferred to nitrocellulose and probed with antibodies for
Western blot analysis.
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